Last updated on April 19, 2014 at 17:21 EDT

Latest Mitomics Inc. Stories

2013-01-07 08:28:37

Diagnostic pathology firm to offer breakthrough prostate cancer assay to urology market THUNDER BAY, ON, Jan. 7, 2013 /PRNewswire/ - Mitomics, a developer of mitochondrial DNA-based tests for early disease detection, today announced it has entered into a sales and marketing agreement for the Prostate Core Mitomic Test((TM)) (PCMT(TM)) with Sterling Pathology National Laboratories. Under the agreement, Sterling Pathology National Laboratories, a leader in diagnostic pathology...

2012-10-10 07:27:33

Urologists Able to Order Prostate Core Mitomic Test((TM)) through LabCorp's DIANON Systems Laboratory THUNDER BAY, ON, Oct. 10, 2012 /PRNewswire/ - Mitomics, a world leader in the research and development of mitochondrial genome-based products, today announced an agreement with Laboratory Corporation of America(® )Holdings (LabCorp(®)) (NYSE: LH), a leading provider of medical laboratory tests and services.  Under the agreement, urologists will be able to order Mitomics'...